Clinical Trials Directory

Trials / Completed

CompletedNCT05285371

Boluses of Ringer's in Surgical Kids (BRiSK Study)

Intravenous Hydration After Surgery Using Boluses of Balanced Salt Solution

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Children's Hospital of Philadelphia · Academic / Other
Sex
All
Age
1 Year – 21 Years
Healthy volunteers
Accepted

Summary

Traditional protocols for intravenous fluid administration in children who have undergone a major abdominal or thoracic operation are based on a landmark paper published in 1957 by Holliday and Segar. The basic tenets include: (1) Continuous intravenous fluid administration; (2) Total fluid volume based on the "4:2:1" rule; (3) Use of hypotonic electrolyte solutions, most commonly 0.45% sodium chloride (NaCl) + 20 milliequivalents per liter (mEq/L) potassium chloride (KCl); and (4) Inclusion of 5% dextrose to increase the osmolarity of the infusate and to help prevent ketosis and acidemia.

Detailed description

Recent studies have questioned the validity of each of these tenets. Maintenance rate as defined by Holliday \& Segar is postulated to be in excess of pediatric patients' post-surgical fluid needs. The investigators propose a novel protocol for the administration of IV fluids to children after major abdominal or thoracic surgery that includes: (1) Intermittent boluses; (2) Total volume administered in 24 hours closer to 2/3 of the traditional maintenance fluid requirements; and (3) Use of a balanced salt solution (Lactated Ringer).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUrinalysis (UA)Urinalysis will be performed twice daily starting on Postoperative Day 0.
DIAGNOSTIC_TESTComplete Metabolic Panel (CMP)A CMP will be performed on Postoperative Day 2 and Postoperative Day 4.
DIAGNOSTIC_TESTGlucose Stick Test (d-Stick)A d-Stick will be performed twice daily except on Postoperative Day 2 and Postoperative Day 4 as the CMP includes serum glucose levels.
OTHERMedical Chart ReviewA medical chart review will be performed for all subjects enrolled.

Timeline

Start date
2022-02-22
Primary completion
2023-04-19
Completion
2024-08-01
First posted
2022-03-17
Last updated
2024-09-19

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05285371. Inclusion in this directory is not an endorsement.